Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma.
Schwartz
J D
JD
Howard
W
W
Scadden
D T
DT
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D020008:Delavirdine / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000009:adverse effects* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D019258:Saquinavir / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy*
D019380:Anti-HIV Agents; D000972:Antineoplastic Agents, Phytogenic; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D020008:Delavirdine; D019258:Saquinavir; D017239:Paclitaxel